Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Analyst Price Target Pulled?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Comment by NewToInvesting7on Mar 30, 2021 10:33pm
151 Views
Post# 32911772

RE:RE:Analyst Price Target Pulled?

RE:RE:Analyst Price Target Pulled?
Nailbiter1 wrote:
NewToInvesting7 wrote: Anyone know why both TD and CIBC are showing the "buy" rating for SZLS, but have removed the price target?  TD removed the price target a last week I believe, and I only noticed it on CIBC today.  Is this  normal before supposed big news releases?

P.S., I also checked the SZLS link on the TMX site, and it's showing zero (0) analyst ratings.

Cheers! 

I noticed this a while back. I brought it up to Rebecca.
She informed me that TMX holds analyst reports for 6 months then removes them.
No worries.


One question Nailbiter1, and this is for my own education.  Does the 6 month apply from the date the original rating was issued, or from the date it was reiterated?  

Only asking since TD is showing the rating as reiterated on 12/08/20, and I am assuming this means December 8, 2020, which is less than 6 months.  Dates confuse me sometimes, since I never know if it is posted as dd/mm/yy or mm/dd/yy.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities